A new study shows that switching from injectable weight-loss drugs like Wegovy and Mounjaro to the oral drug orforglipron significantly reduces weight regain and maintains health benefits after treatment ends, offering a more sustainable and affordable option for obesity care.
Stacked weekly counts; colour by lean. “n/a” covers government and iwi-Māori sources where lean isn't applicable.
How this topic has been named, week by week. A new alias winning out is usually a framing shift.
Up to 12 framings spread across orientations. Each framing is a short phrase the topic extractor generated to characterise the piece's stance — not a quote from the source. Click through to read the original.
regulatory pathway shapes patient access
A pill helps you keep weight off after you come off weight-loss jabs – new studySpotted something wrong on this page? Report a correction.
